{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:06:08Z","timestamp":1776881168965,"version":"3.51.2"},"reference-count":61,"publisher":"American Psychological Association (APA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"DOI":"10.1037\/1064-1297.13.4.282","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T19:15:11Z","timestamp":1135106111000},"page":"282-292","source":"Crossref","is-referenced-by-count":36,"title":["Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation."],"prefix":"10.1037","volume":"13","author":[{"given":"Paul M.","family":"Cinciripini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice Y.","family":"Tsoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cho","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Cinciripini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Baile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Minna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"15","published-online":{"date-parts":[[2005]]},"reference":[{"key":"r1_10.1037\/1064-1297.13.4.282","volume-title":"Multiple regression: Testing and interpreting interactions.","author":"Aiken","year":"1991"},{"key":"r2_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.219"},{"key":"r3_10.1037\/1064-1297.13.4.282","first-page":"395","article-title":"Bupropion: A review of its mechanism of antidepressant activity.","volume":"56","author":"Ascher","year":"1995","journal-title":"The Journal of Clinical Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"r4_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4088\/JCP.v57n1106","article-title":"Development of major depressive disorder during smoking-cessation treatment.","volume":"57","author":"Borrelli","year":"1996","journal-title":"The Journal of Clinical Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"r5_10.1037\/1064-1297.13.4.282","first-page":"242","article-title":"Measuring emotion: Behavior, feeling, and physiology.","volume-title":"Cognitive neuroscience of emotion","author":"Bradley","year":"2000"},{"key":"r6_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.14.1.41"},{"key":"r7_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.4.1.29"},{"key":"r8_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.2.356"},{"key":"r9_10.1037\/1064-1297.13.4.282","volume-title":"Percentage distribution of adult current cigarette smokers, by number of cigarettes smoked per day, and percentage of adult current cigarette smokers who smoked 25 cigarettes per day, by sex, race, Hispanic origin, age, and education (Tobacco Information and Prevention Tips series).","year":"2001"},{"key":"r10_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199506000-00006"},{"key":"r11_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.64.2.314"},{"key":"r12_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.10.1731"},{"key":"r13_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026277907818"},{"key":"r14_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.2.403"},{"key":"r15_10.1037\/1064-1297.13.4.282","first-page":"137","article-title":"Efficacy of venlafaxine and placebo during long-term treatment of depression: A pooled analysis of relapse rates.","volume":"11","author":"Entsuah","year":"1996","journal-title":"International Clinical Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1315","issn-type":"print"},{"key":"r16_10.1037\/1064-1297.13.4.282","first-page":"1200","article-title":"U.S. public health service clinical practice guideline: Treating tobacco use and dependence.","volume":"45","author":"Fiore","year":"2000","journal-title":"Respiratory Care","ISSN":"https:\/\/id.crossref.org\/issn\/0020-1324","issn-type":"print"},{"key":"r17_10.1037\/1064-1297.13.4.282","volume-title":"Structured Clinical Interview for Axis I DSM-IV Disorders. Patient Edition (SCID-II, version 2.0).","author":"First","year":"1994"},{"key":"r18_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.11.2.123"},{"key":"r19_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00423-X"},{"key":"r20_10.1037\/1064-1297.13.4.282","first-page":"438","article-title":"Random regression models: A comprehensive approach to the analysis of longitudinal psychiatric data.","volume":"24","author":"Gibbons","year":"1988","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"r21_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1993.01820210073009","article-title":"Some conceptual and statistical issues in the analysis of logitudintal psychiatric data.","volume":"50","author":"Gibbons","year":"1993","journal-title":"Archives of General Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"r22_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.10.930"},{"key":"r23_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.8.683"},{"key":"r24_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00237-2"},{"key":"r25_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.174.2.173","article-title":"Efficacy of bupropion for smoking cessation in smokers with a former history of major depression and alcoholism.","volume":"174","author":"Hayford","year":"1999","journal-title":"The British Journal of Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"key":"r26_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologie relapse prevention after smoking cessation.","volume":"135","author":"Hays","year":"2001","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"r27_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"r28_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.67.4.547"},{"key":"r29_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00222-5"},{"key":"r30_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.60.5.689"},{"key":"r31_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal.","volume":"43","author":"Hughes","year":"1986","journal-title":"Archives of General Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"r32_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.11.5.331"},{"key":"r33_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1080\/14622200307270"},{"key":"r34_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710233371703"},{"key":"r35_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903043400903"},{"key":"r36_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1097\/00004714-199606002-00005","article-title":"Dose-response relationship with venlafaxine.","volume":"16","author":"Kelsey","year":"1996","journal-title":"Journal of Clinical Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"key":"r37_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.1.216"},{"key":"r38_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1037\/0022-006X.68.5.883","article-title":"Nicotine patch and paroxetine for smoking cessation.","volume":"68","author":"Killen","year":"2000","journal-title":"Journal of Consulting and Clinical Psychology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-006X","issn-type":"print"},{"key":"r39_10.1037\/1064-1297.13.4.282","volume-title":"Tobacco use in America: Findings from the 1999 National Household Survey on Drug Abuse (Analytic series: A-15; DHHS Publication No. SMA 02-3622).","author":"Kopstein","year":"2001"},{"key":"r40_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00067-4"},{"key":"r41_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/bmj.313.7061.862","article-title":"Interaction 3: How to examine heterogeneity.","volume":"313","author":"Matthews","year":"1996","journal-title":"British Medical Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"r42_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models.","author":"McCullagh","year":"1989","edition":"2nd ed."},{"key":"r43_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100100588"},{"key":"r44_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199503002-00003","article-title":"Pharmacologie profile and efficacy of venlafaxine.","volume":"10","author":"Mendlewicz","year":"1995","journal-title":"International Clinical Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1315","issn-type":"print"},{"key":"r45_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.4.887"},{"key":"r46_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.107.2.238"},{"key":"r47_10.1037\/1064-1297.13.4.282","first-page":"39","article-title":"Why women smoke.","volume-title":"Drug and Alcohol Abuse Reviews","author":"Pomerleau","year":"1994"},{"key":"r48_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.18.2035"},{"key":"r49_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: A self-report depression scale for research in the general population.","volume":"1","author":"Radloff","year":"1977","journal-title":"Applied Psychological Measurement","ISSN":"https:\/\/id.crossref.org\/issn\/0146-6216","issn-type":"print"},{"key":"r50_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0025-6196(12)61375-5","article-title":"Pharmacology of antidepressants: Characteristics of the ideal drug.","volume":"69","author":"Richelson","year":"1994","journal-title":"Mayo Clinic Proceedings","ISSN":"https:\/\/id.crossref.org\/issn\/0025-6196","issn-type":"print"},{"key":"r51_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1097\/00004714-199606002-00011","article-title":"The safety and tolerability of venlafaxine hydrochloride: Analysis of the clinical trials database.","volume":"16","author":"Rudolph","year":"1996","journal-title":"Journal of Clinical Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"key":"r52_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4088\/JCP.v59n0305","article-title":"A randomized, placeho-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.","volume":"59","author":"Rudolph","year":"1998","journal-title":"The Journal of Clinical Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"r53_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006986824213"},{"key":"r54_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.64.2.366"},{"key":"r55_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/ajp.154.4.490","article-title":"Serotonergic modulation of dopa-mine measured with [11 C]raclopride and PET in normal human subjects.","volume":"154","author":"Smith","year":"1997","journal-title":"The American Journal of Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"r56_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04724-3"},{"key":"r57_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.54.6.1063"},{"key":"r58_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.67.4.555"},{"key":"r59_10.1037\/1064-1297.13.4.282","doi-asserted-by":"crossref","unstructured":"Wolfinger. Covariance structure selection in general mixed models. Communications in Statistics 22 1079 1993","DOI":"10.1080\/03610919308813143"},{"key":"r60_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1038\/74839"},{"key":"r61_10.1037\/1064-1297.13.4.282","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.60.6.943"}],"container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psycnet.apa.org\/journals\/pha\/13\/4\/282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T17:53:09Z","timestamp":1707241989000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.apa.org\/doi\/10.1037\/1064-1297.13.4.282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005]]}},"alternative-id":["2005-15800-002","16366758"],"URL":"https:\/\/doi.org\/10.1037\/1064-1297.13.4.282","relation":{},"ISSN":["1936-2293","1064-1297"],"issn-type":[{"value":"1936-2293","type":"electronic"},{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}